HealthWatch examines a major study that sheds new light on the issue of intensive sugar-lowering therapy. It finds that the intensive sugar-lowering treatment increases death rate. The study has been conducted by the Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD).
The study trial was designed to see if intensive therapy for Type 2 diabetes would, in fact, reduce the risk of developing heart attacks and strokes or even of dying from these. More than 10,000 patients were randomly assigned to one of two groups. In the intensive therapy group, patients and doctors used multiple diabetic medications, and in some cases, insulin, as well as close sugar monitoring and frequent visits to keep sugars low - aiming for a HbA1c of no more than six per cent.
The comparison group was treated in a more conventional manner, with at least three visits per year and a target HbA1c of seven to 7.9 per cent. Both study groups were similar at the start of the trial and received the same treatments other than diabetic therapy and both did a pretty good job achieving their sugar targets .
It can be added that in type 2 diabetes the pancreas does not produce enough insulin, or your body does not properly use the insulin it makes.While some people with Type 2 diabetes can manage it through dietary measures and exercise, most need to take oral medications or insulin injections. Research in Type 2 diabetes has consistently shown a relationship between excess glucose levels and diabetic complications, so having amounts in the normal or near normal range is associated with reduced complications, but the link to mortality has been less clear.
Source: The Gazette
Filed under Blood Sugar Testing, Diabetes, Diabetes awareenss, NIDDM, Obesity | Tags: diabetic therapy, Fact, HealthWatch, multiple diabetic medications, sugar targets ., type 2 diabetes | Comment Below